Market open
Poseida Therapeutics/$PSTX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Poseida Therapeutics
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.
Ticker
$PSTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
337
Website
PSTX Metrics
BasicAdvanced
$285M
Market cap
-
P/E ratio
-$1.19
EPS
0.52
Beta
-
Dividend rate
Price and volume
Market cap
$285M
Beta
0.52
52-week high
$4.27
52-week low
$1.87
Average daily volume
498K
Financial strength
Current ratio
2.483
Quick ratio
2.443
Long term debt to equity
127.619
Total debt to equity
137.549
Interest coverage (TTM)
-13.14%
Management effectiveness
Return on assets (TTM)
-25.54%
Return on equity (TTM)
-115.00%
Valuation
Price to revenue (TTM)
3.152
Price to book
4.68
Price to tangible book (TTM)
5.15
Price to free cash flow (TTM)
1,315.671
Growth
Revenue change (TTM)
-43.55%
Earnings per share change (TTM)
240.30%
3-year earnings per share growth (CAGR)
-22.63%
What the Analysts think about PSTX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Poseida Therapeutics stock.
PSTX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
PSTX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
PSTX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Poseida Therapeutics stock?
Poseida Therapeutics (PSTX) has a market cap of $285M as of November 08, 2024.
What is the P/E ratio for Poseida Therapeutics stock?
The price to earnings (P/E) ratio for Poseida Therapeutics (PSTX) stock is 0 as of November 08, 2024.
Does Poseida Therapeutics stock pay dividends?
No, Poseida Therapeutics (PSTX) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next Poseida Therapeutics dividend payment date?
Poseida Therapeutics (PSTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Poseida Therapeutics?
Poseida Therapeutics (PSTX) has a beta rating of 0.52. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.